Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma

Jeffrey Weber, Michael Millward

Research output: Contribution to journalArticle

740 Citations (Scopus)

Fingerprint Dive into the research topics of 'Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences